Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research-Reference-Cited by-同舟云学术

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

Published:2021-05-25 Issue:6 Volume:42 Page:785-793
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Virani Shama¹^ORCID,Baiocchi Glauco²,Bowtell David³,Cabasag Citadel J⁴,Cho Kathleen R⁵,Fortner Renée T⁶,Fujiwara Keiichi⁷,Kim Jae-Weon⁸,Köbel Martin⁹,Kurtz Jean-Emmanuel¹⁰,Levine Douglas A¹¹,Menon Usha¹²^ORCID,Norquist Barbara M¹³^ORCID,Pharoah Paul D P¹⁴,Sood Anil K¹⁵,Tworoger Shelley T¹⁶^ORCID,Wentzensen Nicolas¹⁷^ORCID,Chanock Stephen J¹⁷^ORCID,Brennan Paul¹,Trabert Britton¹⁷^ORCID

Affiliation:

1. International Agency for Research on Cancer (IARC/WHO), Genomic Epidemiology Branch, Lyon, France

2. Department of Gynecology Oncology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil

3. Women’s Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

4. Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France

5. Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA

6. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

7. Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Tokyo, Japan

8. Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea

9. Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

10. Department of Medical and Surgical Oncology and Hematology, Strasbourg Cancer Institute (ICANS-Europe), Strasbourg, France

11. Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA

12. MRC CTU at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK

13. Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA

14. Department of Oncology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK

15. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

16. Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

17. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA

Abstract

Abstract Recently, ovarian cancer research has evolved considerably because of the emerging recognition that rather than a single disease, ovarian carcinomas comprise several different histotypes that vary by etiologic origin, risk factors, molecular profiles, therapeutic approaches and clinical outcome. Despite significant progress in our understanding of the etiologic heterogeneity of ovarian cancer, as well as important clinical advances, it remains the eighth most frequently diagnosed cancer in women worldwide and the most fatal gynecologic cancer. The International Agency for Research on Cancer and the United States National Cancer Institute jointly convened an expert panel on ovarian carcinoma to develop consensus research priorities based on evolving scientific discoveries. Expertise ranged from etiology, prevention, early detection, pathology, model systems, molecular characterization and treatment/clinical management. This report summarizes the current state of knowledge and highlights expert consensus on future directions to continue advancing etiologic, epidemiologic and prognostic research on ovarian carcinoma.

Funder

International Agency for Research on Cancer

Division of Cancer Epidemiology and Genetics, National Cancer Institute

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/advance-article-pdf/doi/10.1093/carcin/bgab043/38673049/bgab043.pdf

Reference100 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018